Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.11.2011 | Case report

Alglucosidase-α

Hypersensitivity in paediatric patients: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat El-Gharbawy AH, Mackey J, DeArmey S, Westby G, Grinnell SG, Malovrh P, Conway R, Kishnani PS.An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions. Molecular Genetics and Metabolism 104: 118-122, No. 12, Sep 2011. Available from: URL: http://dx.doi.org/10.1016/j.ymgme.2011.07.004 - USA El-Gharbawy AH, Mackey J, DeArmey S, Westby G, Grinnell SG, Malovrh P, Conway R, Kishnani PS.An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions. Molecular Genetics and Metabolism 104: 118-122, No. 12, Sep 2011. Available from: URL: http://​dx.​doi.​org/​10.​1016/​j.​ymgme.​2011.​07.​004 - USA
Metadaten
Titel
Alglucosidase-α
Hypersensitivity in paediatric patients: 2 case reports
Publikationsdatum
01.11.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113760-00014

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Azathioprine

Case report

Isotretinoin

Case report

Sildenafil

Case report

Tenofovir